Decreased cell cycle progression during hematopoiesis and reduced blood cell production can be associated with increased tumorigenesis, such as in E2F1/E2F2 mutant mice, people with inadequate folate intake, and during particular chemotherapeutic regimens. We propose a hypothesis whereby reduced proliferation of blood progenitors selects for oncogenic mutations that improve cell cycle progression. Basically, impeded proliferation of progenitor cells provides for poor competition, promoting the expansion of progenitors that acquire oncogenic mutations. As cancer development has clear attributes reminiscent of Darwinian evolution, it is perhaps not surprising that it should become easier for a mutant cell clone to be the fittest as the quality of the competition declines. Contexts which involve nucleotide deprivation and DNA damage, and thus impeded DNA replication, often enhance mutation accumulation, and we propose that mutator phenotypes synergize with poor competition to promote tumorigenesis. We suggest that the poorly competitive progenitor environments that result from folate deficiency, particular inherited polymorphisms, and certain chemotherapeutic treatments contribute to increased cancer risk in affected people. To test our hypothesis, we will introduce the oncogenic Bcr-Abl and E2a-Hlf translocation products into mouse BM stem cells using retroviral transduction, and then reconstitute hematopoiesis in recipient mice using these stem cells. We will ask how genetic, dietary and chemotherapeutic contexts that impair cell cycle progression in blood progenitor cells affect the ability of oncogene expressing cells to competitively expand and contribute to leukemogenesis. We will also investigate the mechanism whereby each oncogene improves cell proliferation in compromised progenitors, such as by bypassing checkpoints and restoring DNA synthesis. We anticipate that particular conditions that impair S phase progression will promote the expansion and tumorigenicity of oncogene expressing progenitor cells. These studies should define novel factors governing tumorigenesis, and will create unique model systems that could suggest further epidemiological studies in humans.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA109657-05
Application #
7647304
Study Section
Cancer Molecular Pathobiology Study Section (CAMP)
Program Officer
Mufson, R Allan
Project Start
2005-09-13
Project End
2011-06-30
Budget Start
2009-07-01
Budget End
2011-06-30
Support Year
5
Fiscal Year
2009
Total Cost
$214,532
Indirect Cost
Name
University of Colorado Denver
Department
Biochemistry
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Porter, C C; Kim, J; Fosmire, S et al. (2012) Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia. Leukemia 26:1266-76
Bahmed, Karim; Henry, Curtis; Holliday, Michael et al. (2012) Extracellular cyclophilin-A stimulates ERK1/2 phosphorylation in a cell-dependent manner but broadly stimulates nuclear factor kappa B. Cancer Cell Int 12:19
DeGregori, James (2011) Evolved tumor suppression: why are we so good at not getting cancer? Cancer Res 71:3739-44
Porter, C C; Baturin, D; Choudhary, R et al. (2011) Relative fitness of hematopoietic progenitors influences leukemia progression. Leukemia 25:891-5
Degregori, James (2011) A new role for E2F1 in DNA repair: all for the greater good. Cell Cycle 10:1716
Schaack, Jerome; Bennett, Michael L; Shapiro, Gary S et al. (2011) Strong foreign promoters contribute to innate inflammatory responses induced by adenovirus transducing vectors. Virology 412:28-35
Henry, Curtis J; Marusyk, Andriy; DeGregori, James (2011) Aging-associated changes in hematopoiesis and leukemogenesis: what's the connection? Aging (Albany NY) 3:643-56
Le, Oanh N L; Rodier, Francis; Fontaine, Francois et al. (2010) Ionizing radiation-induced long-term expression of senescence markers in mice is independent of p53 and immune status. Aging Cell 9:398-409
Alvarez, D F; Helm, K; Degregori, J et al. (2010) Publishing flow cytometry data. Am J Physiol Lung Cell Mol Physiol 298:L127-30
Gregory, Mark A; Phang, Tzu L; Neviani, Paolo et al. (2010) Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl. Cancer Cell 18:74-87

Showing the most recent 10 out of 21 publications